So, Hims & Hers is talking to Novo Nordisk about selling Wegovy? Let me get this straight. The same Hims & Hers that built its brand on affordable, accessible healthcare is now cozying up to Novo Nordisk? The Novo Nordisk that charges an arm and a leg for weight loss drugs? Color me shocked. Actually, no, color me cynical. I saw this coming a mile away.
The Inevitable Sellout
It was only a matter of time before Hims & Hers, like every other "disruptive" startup, decided to cash in. Remember when they were all about democratizing healthcare? About making things easier and cheaper for the average person? Yeah, well, that was cute while it lasted. Now they're looking at a big payday, and suddenly, principles go out the window.
I mean, give me a break. We're supposed to believe that this is about "expanding access" or some other BS corporate jargon? Please. This is about lining pockets. It's always about lining pockets.
And what about the customers who bought into the whole Hims & Hers ethos? The ones who trusted them to be different? The ones who actually benefited from their affordable services? What happens to them when Novo Nordisk takes over? Do you think they're going to keep prices low out of the goodness of their hearts? Ofcourse not.
The Wegovy Hypocrisy
Let's talk about Wegovy for a second. It's a weight loss drug that actually works... if you can afford it. And that's the problem, isn't it? It's priced so high that it's completely inaccessible to most people who need it. So, Hims & Hers, a company that supposedly cares about accessibility, is now going to be selling a drug that's the very definition of inaccessibility?
The irony is thicker than a milkshake.
I just... I can't even. It's like watching your favorite indie band sign a deal with a major label and suddenly start churning out generic pop songs. You feel betrayed. You feel like you were lied to.
I wonder what the internal meetings at Hims & Hers are like right now. Are they patting themselves on the back for their brilliant business strategy? Are they even remotely concerned about the ethical implications of this deal? Or are they too busy counting their future millions?
Then again, maybe I'm the crazy one here. Maybe I'm expecting too much from a company that's ultimately just trying to make money. But I can't shake the feeling that this is a betrayal of everything Hims & Hers was supposed to stand for.
What's Next?
What's the endgame here? Will Hims & Hers eventually be fully absorbed by Novo Nordisk? Will they become just another cog in the Big Pharma machine? It's hard to say. Details are scarce, and the companies aren't exactly being transparent about their plans. Hims & Hers Health in discussions with Novo Nordisk to sell Wegovy
But one thing is clear: this is a turning point for Hims & Hers. They're at a crossroads, and they've chosen the path of profit over principle. And honestly, I can't say I'm surprised.
Another One Bites the Dust
I'm not even mad, just disappointed. It's the same old story: startup promises disruption, gains a loyal following, then sells out to the highest bidder. Rinse and repeat. The only real innovation here is the speed at which these companies abandon their original mission.
